Research Highlights Trends in Cal/BD Foam Psoriasis Treatment for Medicare Patients
HCP Live,
New research highlights the growing number of claims among all providers, including advanced practice practitioners and non-derma…
Annual trends in Medicare part D prescription claims for calcipotriene/betamethasone dipropionate foam for psoriasis 2016–2020
Overview of attention for article published in International Journal of Dermatology, December 2022
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
Good Attention Score compared to outputs of the same age (77th percentile)
-
High Attention Score compared to outputs of the same age and source (85th percentile)
Readers on
- mendeley
- 2 Mendeley